Targacept (TRGT) 2.43 $TRGT 3 Stocks Under $10 to Trade

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Targacept (TRGT) 2.43 $TRGT

3 Stocks Under $10 to Trade for Big Breakouts
at The Street - Thu Apr 23, 12:57PM CDT
These under-$10 stocks are within range of triggering breakout trades.
DHRM: 3.02 (-0.05), TRGT: 2.43 (+0.04), SLTD: 4.54 (+0.14)

Targacept, Inc. - Product Pipeline Review - 2014
M2 - Mon Apr 20, 3:19AM CDT
Product Pipeline Review - 2014
TRGT: 2.43 (+0.04)

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 6:36PM CDT
Targacept, Inc. announced disappointing top-line data from a phase I/II exploratory study on its candidate TC-6499 for the treatment of diabetic gastroparesis.
CYTK: 7.25 (-0.18), VRX: 210.42 (+1.03), TRGT: 2.43 (+0.04), PFE: 35.27 (-0.09)

Targacept gastroparesis candidate flunks clinical trial
Seeking Alpha - at Seeking Alpha - Thu Apr 16, 9:51AM CDT

TRGT: 2.43 (+0.04)

Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis
Business Wire - Thu Apr 16, 7:30AM CDT
Targacept, Inc. (NASDAQ: TRGT) today announced top-line results from a Phase 1/2 exploratory study of TC-6499 as a treatment for diabetic gastroparesis, a chronic disorder that slows or stops the passage of food from the stomach to the small intestine. In the trial, TC-6499 did not meet the primary endpoint of the study, change in gastric emptying half-time (BT_t1/2), as measured by a carbon ((13)C) labeled gastric emptying breath test, relative to placebo.
TRGT: 2.43 (+0.04)

BUYINS.NET: SIRO, TRGT, SBGI, EMR, MDC, HEP Expected To Be Up Before Next Earnings Releases
M2 - Wed Apr 15, 6:13AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. Sirona Dental Systems Inc (NASDAQ:SIRO), Targacept Inc (NASDAQ:TRGT), Sinclair Broadcast Group Inc (NASDAQ:SBGI), Emerson Electric Co (NYSE:EMR), MDC Holdings Inc (NYSE:MDC), Holly Energy Partners LP (NYSE:HEP) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Friday:
HEP: 34.29 (+0.53), SIRO: 94.43 (+0.13), MDC: 27.53 (+0.52), TRGT: 2.43 (+0.04), EMR: 57.65 (-0.56), SBGI: 31.40 (+0.10)

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Press Releases
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead
GILD: 103.69 (-1.52), TRGT: 2.43 (+0.04), JUNO: 56.66 (-1.06), RGLS: 17.49 (-0.80), ALKS: 62.26 (-1.19)

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 08, 1:53PM CDT
With first quarter earnings season yet to start, it was a relatively slow week for the biotech sector.
GILD: 103.69 (-1.52), TRGT: 2.43 (+0.04), AMGN: 167.91 (-1.26), JUNO: 56.66 (-1.06), RGLS: 17.49 (-0.80), ALKS: 62.26 (-1.19), CELG: 118.71 (+2.62)

Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 2:30PM CDT
Targacept (TRGT) crumbled after Catalyst informed that Pfizer (PFE) will be terminating its agreement with Catalyst Biosciences.
TRGT: 2.43 (+0.04), PFE: 35.27 (-0.09), AZN: 71.79 (-1.34), AFFX: 12.44 (-0.16)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 06, 11:44AM CDT

HK: 1.57 (-0.04), TOF: 4.80 (+0.59), VTAE: 14.05 (+0.12), NYMX: 1.39 (-0.05), VLTC: 11.54 (+0.50), CGNT: 1.70 (-0.01), RESN: 3.90 (+0.06), MHR: 2.26 (-0.14), GBSN: 4.17 (-0.53), NATH: 46.49 (-0.22), INUV: 2.22 (-0.02), ATNM: 2.95 (-0.08), SYPR: 1.55 (+0.01), TRGT: 2.43 (+0.04), QURE: 26.09 (-0.28), CYTX: 0.99 (+0.01), PRXI: 4.55 (-0.10), NPTN: 5.56 (-0.34), CBMG: 29.51 (-1.85), SA: 6.20 (-0.13)

Targacept off 11% after Pfizer backs out of collaboration with Catalyst Bio
Seeking Alpha - at Seeking Alpha - Mon Apr 06, 9:51AM CDT

TRGT: 2.43 (+0.04), PFE: 35.27 (-0.09)

BUYINS.NET: DSW, ITRN, PLTM, TRGT, AHGP, PSL Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Mar 30, 9:45AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of DSW Inc (NYSE SW), Ituran Location and Control Ltd (NASDAQ:ITRN), First Trust Ise Global Platinum Index Fund (NASDAQ LTM), Targacept Inc (NASDAQ:TRGT), Alliance Holdings GP LP (NASDAQ:AHGP), Powershares Dynamic Consumer Staples Sector Portfolio (NYSE SL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DSW: 39.14 (+1.37), PLTM: 9.36 (-0.02), AHGP: 50.19 (-0.39), TRGT: 2.43 (+0.04), ITRN: 23.44 (+0.12), PSL: 53.42 (-0.27)

Nasdaq stocks posting largest volume increases
AP - Wed Mar 25, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
WBB: 17.20 (-0.11), OTIV: 1.50 (-0.10), TRGT: 2.43 (+0.04), SEED: 1.77 (+0.16), ORMP: 7.45 (+0.08), FCAP: 24.35 (-0.53), ASUR: 5.40 (-0.19), LIME: 2.83 (-0.06), KRFT: 87.57 (-0.81), VBLT: 4.23 (+0.07), FNJN: 1.39 (-0.06), DGLY: 13.88 (+0.39), KFX: 11.02 (-0.01)

Seeking Alpha's Biotech Weekly: Deeper Looks At Orexigen, Pharmacyclics, And Acadia
SA Editor Mike Taylor - Seeking Alpha - Fri Mar 13, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ACT: 295.41 (-2.95), PCYC: 256.59 (-0.51), ITEK: 5.61 (+0.86), REDX: (), PTX: 7.09 (-0.24), CLDX: 30.10 (+0.19), ILMN: 189.59 (-3.01), IDGX: (), ACAD: 38.36 (-0.54), TRGT: 2.43 (+0.04), CLLS: 32.61 (-0.07), EXAC: 24.40 (+0.15), ABBV: 66.07 (+1.82), CRMD: 8.61 (-0.22), AGMX: (), ZGNX: 1.54 (-0.11), VVUS: 2.46 (-0.04), SPPI: 6.10 (+0.07), GSK: 46.59 (+0.28), OREX: 7.36 (-0.08), SQNM: 4.52 (-0.10), IRWD: 15.10 (-0.38), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), OHRP: 2.94 (+0.12), TEVA: 64.41 (+1.16)

Why I Am Still Long Targacept After The Reverse Merger Announcement
Daniel Ward - at Seeking Alpha - Tue Mar 10, 11:08AM CDT

NVO: 56.65 (+0.44), TRGT: 2.43 (+0.04), PFE: 35.27 (-0.09)

Targacept and Catalyst Bio to merge
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 9:36PM CST

TRGT: 2.43 (+0.04)

Biotech Weekly: When To Dash For The Trash (And When Not To)
Daniel Ward - at Seeking Alpha - Mon Feb 02, 8:40AM CST

KBIO: 0.53 (-0.03), CYCC: 0.96 (+0.02), TRGT: 2.43 (+0.04), SPHS: 0.80 (-0.03), ABIO: 0.88 (-0.04), APPY: 0.56 (+0.01), OCLS: 0.85 (+0.03)

Biotech Weekly: Top Value Biotech Picks For 2015
Daniel Ward - at Seeking Alpha - Mon Jan 05, 8:01AM CST

ROSG: 3.72 (+0.06), ECYT: 6.17 (-0.13), TRGT: 2.43 (+0.04), OGXI: 2.19 (+0.04), BOTA: 2.41 (+0.08), XBI: 233.86 (-2.86), DARA: 0.81 (+0.04), RGDO: 1.42 (+0.13), REPH: 11.88 (+1.04)

Biotech Weekly: Here Come The Institutional Holdings Updates
Daniel Ward - at Seeking Alpha - Mon Nov 17, 7:31AM CST

LOXO: 13.60 (+0.21), TRGT: 2.43 (+0.04), BOTA: 2.41 (+0.08), XBI: 233.86 (-2.86), IBB: 363.70 (-3.98), BIOS: 5.26 (+0.01), RGDO: 1.42 (+0.13), EXEL: 3.08 (-0.02), AMPH: 15.25 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 55

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 44

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 42

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 37

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 55

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 42

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kiavi Launches Major $300 Million Securitization Milestone

Updated Category News Views 292

Kiavi's Significant Securitization Achievement Kiavi, a prominent tech-enabled lender catering to residential real estate investors, has recently made headlines by closing a prominent $300 million rated securitization of residential transition loans (RTLs). This transaction marks Kiavi's 21st under its LHOME shelf, pushing the total to an impressive $5.8 billion in...

Continue Reading
The AI Landscape at CES 2025: Nvidia vs AMD in Focus

Updated Category News Views 285

Current State of the Semiconductor Industry The semiconductor industry is witnessing an exciting showdown between two titans: Nvidia Corp (NASDAQ: NVDA) and Advanced Micro Devices, Inc. (NASDAQ: AMD). Both companies are pivotal players in the race to dominate AI technology, and their journeys are marked by stark contrasts. While Nvidia has been enjoying a remarkable...

Continue Reading
First National Bank Alaska Announces December Dividend Details

Updated Category News Views 104

Overview of Dividend Declarations First National Bank Alaska has recently made an important announcement regarding its dividend payments for the fourth quarter. Following a meeting of the Board of Directors, the bank declared both a regular and a special cash dividend, ensuring shareholders are rewarded for their investment. Regular Cash Dividend Details The regular cash...

Continue Reading
Gilmore Bell Expands Team with New Shareholders in Missouri

Updated Category News Views 161

Gilmore Bell Welcomes New Shareholders Gilmore & Bell, P.C., a prominent public finance law firm, is excited to share recent developments in its Kansas City office. The firm proudly announces the appointment of Laura Connor and Megan Miller as new shareholders, reflecting their commitment to excellence in legal services. About Laura Connor Laura Connor brings a wealth of...

Continue Reading
Westamerica Bancorporation Boosts Shareholder Value with Dividend

Updated Category News Views 108

Westamerica Bancorporation Announces Quarterly Cash Dividend The Board of Directors at Westamerica Bancorporation (NASDAQ: WABC) has made a significant decision to declare a quarterly cash dividend aimed at rewarding its valued shareholders. This dividend is set at $0.44 per share for all common stock outstanding, emphasizing the company's dedication to maintaining...

Continue Reading